Publications

  1. Gupta S, Sukov WR, Vanderbilt CM, Shen W, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Cheville JC. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma. Urol Oncol. 2022 Dec; 40 (12):512-524 Epub 2021 June 04
    View PubMed
  2. Gupta S, Erickson LA. The Cytogenetic Profile of Spindle Cell-Predominant Mucinous Tubular and Spindle Cell Carcinoma. Mayo Clin Proc. 2022 Dec; 97 (12):2387-2388
    View PubMed
  3. Raghunathan A, Ida CM, Westbroek EM, Gupta S, Jenkins RB, Giannini C, Aldape KD. Mutations of FH and IDH may induce gliomagenesis by similar mechanisms. J Neuropathol Exp Neurol. 2022 Nov 11 [Epub ahead of print]
    View PubMed
  4. Gupta S, Nichols P, Lohse CM, Kosari F, Kattah AG, Harris FR, Karagouga G, Mehra R, Fine SW, Reuter VE, Herrera-Hernandez L, Zganjar AJ, Britton CJ, Potretzke AM, Boorjian SA, Thompson RH, Jimenez RE, Leibovich BC, Garovic VD, Cheville JC, Sharma V. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors. Mayo Clin Proc. 2022 Nov; 97 (11):2050-2064 Epub 2022 June 24
    View PubMed
  5. Gupta S, Stanton ML, Reynolds JP, Whaley RD, Herrera-Hernandez L, Jimenez RE, Cheville JC. Lessons from histopathologic examination of nephrectomy specimens in patients with tuberous sclerosis complex: cysts, angiomyolipomas, and renal cell carcinoma. Hum Pathol. 2022 Nov; 129:123-139 Epub 2022 Sept 14
    View PubMed
  6. McCarthy MR, Nichols PE, Sharma V, Stanton ML, Reynolds JP, Pitel BA, Halling KC, Lohse CM, Herrera-Hernandez L, Thompson RH, Leibovich BC, Jimenez RE, Boorjian SA, Cheville JC, Gupta S. Molecular and Immunophenotypic Correlates of Metastatic Epithelioid Angiomyolipoma Include Alterations of TP53, RB1, and ATRX. Arch Pathol Lab Med. 2022 Oct 31 [Epub ahead of print]
    View PubMed
  7. Mannan R, Wang X, Bawa PS, Zhang Y, Skala SL, Chinnaiyan AK, Dagar A, Wang L, Zelenka-Wang SB, McMurry LM, Daniel N, Cao X, Sangoi AR, Gupta S, Vaishampayan UN, Hafez KS, Morgan TM, Spratt DE, Tretiakova MS, Argani P, Chinnaiyan AM, Dhanasekaran SM, Mehra R. Characterization of Intercalated Cell Markers KIT and LINC01187 in Chromophobe Renal Cell Carcinoma and Other Renal Neoplasms. Int J Surg Pathol. 2022 Oct 16; 10668969221125793 [Epub ahead of print]
    View PubMed
  8. Gupta S, Folpe AL, Torres-Mora J, Reuter VE, Zuckerman JE, Falk N, Stanton ML, Muthusamy S, Smith SC, Sharma V, Sethi S, Herrera-Hernandez L, Jimenez RE, Cheville JC. Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors. Hum Pathol. 2022 Oct; 128:110-123 Epub 2022 Aug 01
    View PubMed
  9. Kerper AL, Clarke-Brodber AL, Gupta S, Whalen KM, Nigdelioglu R, Boland JM, Schembri Wismayer DJ, Torres-Mora J, Mejia Acevedo MR, Sudhindran V, Sturgis CD. Malignant rhabdoid tumor: Cyto-histologic correlation and immunohistochemical characterization of a rare pediatric malignancy and its differential diagnoses. Ann Diagn Pathol. 2022 Oct; 60:152014 Epub 2022 July 22
    View PubMed
  10. Zafar R, Schrader LJ, Cheville JC, Schoolmeester JK, Roden AC, Aubry MC, Yi ES, Raghunathan A, Herrera-Hernandez L, Thompson RH, Boorjian SA, Leibovich BC, Keeney GL, Jimenez RE, Gupta S. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma. Hum Pathol. 2022 Oct; 128:31-47 Epub 2022 July 06
    View PubMed
  11. Gupta S, Erickson LA. Prepubertal-Type Testicular Tumors in Postpubertal Patients: Epidermoid Cyst and Well-Differentiated Neuroendocrine Tumor. Mayo Clin Proc. 2022 Oct; 97 (10):1956-1957
    View PubMed
  12. Gupta S, Guo R, Erickson LA. Anaplastic Thyroid Carcinoma, Squamous Cell Carcinoma Pattern. Mayo Clin Proc. 2022 Aug; 97 (8):1584-1585
    View PubMed
  13. Gupta S, Erickson LA. Postirradiation Angiosarcoma of the Urinary Bladder. Mayo Clin Proc. 2022 Jul; 97 (7):1406-1408
    View PubMed
  14. Mahmoud AM, Frank I, Orme JJ, Lavoie RR, Thapa P, Costello BA, Cheville JC, Gupta S, Dong H, Lucien F. Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancer. BMC Urol. 2022 Jun 24; 22 (1):90 Epub 2022 June 24
    View PubMed
  15. McCarthy MR, Tiegs-Heiden CA, Sturgis CD, Swanson AA, Gupta S, Thangaiah JJ, Hartley CP. Biphasic squamoid alveolar renal cell carcinoma: Cytologic features of a rare entity. Ann Diagn Pathol. 2022 Jun; 58:151906 Epub 2022 Feb 03
    View PubMed
  16. Carlo MI, Attalla K, Mazaheri Y, Gupta S, Yildirim O, Murray SJ, Coskey DT, Kotecha R, Lee CH, Feldman DR, Russo P, Patil S, Motzer RJ, Coleman JA, Durack JC, Chen YB, Akin O, Ari Hakimi A, Voss MH. Phase II Study of Neoadjuvant Nivolumab in Patients with Locally Advanced Clear Cell Renal Cell Carcinoma Undergoing Nephrectomy. Eur Urol. 2022 Jun; 81 (6):570-573 Epub 2022 Feb 17
    View PubMed
  17. Gupta S, Farooq A, Rowsey RA, Rahman MA, Shen W, Herrera-Hernandez L, Raghunathan A, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC, Jimenez RE. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants. Hum Pathol. 2022 Jun; 124:85-95 Epub 2022 Apr 01
    View PubMed
  18. Gupta S, Won H, Chadalavada K, Nanjangud GJ, Chen YB, Al-Ahmadie HA, Fine SW, Sirintrapun SJ, Strong VE, Raj N, Lagunes DR, Vanderbilt CM, Berger MF, Ladanyi M, Dogan S, Tickoo SK, Reuter VE, Gopalan A. TERT Copy Number Alterations, Promoter Mutations and Rearrangements in Adrenocortical Carcinomas. Endocr Pathol. 2022 Jun; 33 (2):304-314 Epub 2021 Sept 22
    View PubMed
  19. Gupta S, Herrera-Hernandez L, Erickson LA. Amyloid Involving the Seminal Vesicles. Mayo Clin Proc. 2022 Jun; 97 (6):1213-1214
    View PubMed
  20. Chatzopoulos K, Aubry MC, Gupta S. Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions. Hum Pathol. 2022 May; 123:93-101 Epub 2022 Feb 20
    View PubMed
  21. Vanderbilt CM, Bowman AS, Middha S, Petrova-Drus K, Tang YW, Chen X, Wang Y, Chang J, Rekhtman N, Busam KJ, Gupta S, Hameed M, Arcila ME, Ladanyi M, Berger MF, Dogan S, Zehir A. Defining Novel DNA Virus-Tumor Associations and Genomic Correlates Using Prospective Clinical Tumor/Normal Matched Sequencing Data. J Mol Diagn. 2022 May; 24 (5):515-528 Epub 2022 Mar 22
    View PubMed
  22. Gupta S, Menon S, Raghunathan A, Herrera-Hernandez L, Jimenez RE, Cheville JC. Do We Have Sufficient Evidence to Define Prognosis for "Low-grade" Fumarate Hydratase-deficient Renal Cell Carcinoma? Adv Anat Pathol 2022 May 1; 29 (3):178-181
    View PubMed
  23. Gupta S, Erickson LA. Papillary Renal Cell Carcinoma With "Drop Metastasis" (Tumor Seeding) Involving the Distal Ureter. Mayo Clin Proc. 2022 May; 97 (5):1026-1028
    View PubMed
  24. Momeni-Boroujeni A, Yousefi E, Gupta S, Benayed R, Berger MF, Ladanyi M, Monroe R, Kim J, Jungbluth A, Weigelt B, Park KJ. Evaluation of TERT mRNA expression using RNAscope(R): A potential histopathologic diagnostic and prognostic tool. Pathol Res Pract. 2022 May; 233:153892 Epub 2022 Apr 16
    View PubMed
  25. Erickson LA, Gupta S. STAT6 Immunopositivity in Solitary Fibrous Tumor of Thyroid Gland. Mayo Clin Proc. 2022 Apr; 97 (4):808-810
    View PubMed
  26. Gupta S, Swanson AA, Erickson LA. Renal Cell Carcinoma With Combined Loss of Fumarate Hydratase and SMARCB1/INI-1. Mayo Clin Proc. 2022 Mar; 97 (3):630-632
    View PubMed
  27. Gupta S, Lohse CM, Rowsey R, McCarthy MR, Shen W, Herrera-Hernandez L, Boorjian SA, Houston Thompson R, Jimenez RE, Leibovich BC, Cheville JC. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex-associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome. Eur Urol. 2022 Mar; 81 (3):229-233 Epub 2021 Dec 06
    View PubMed
  28. Taylor AS, Newell B, Chinnaiyan AM, Hafez KS, Weizer AZ, Spratt DE, Cameron AP, Al-Ahmadie HA, Gupta S, Montgomery JS, Betz BL, Brown N, Mehra R. TERT Promoter Mutations in Keratinizing and Nonkeratinizing Squamous Metaplasia of the Urinary Tract. Eur Urol Open Sci. 2022 Jan; 35:74-78 Epub 2022 Jan 03
    View PubMed
  29. Gupta S, Lipworth R, Mynderse LA. Papillary Urothelial Carcinoma. Mayo Clin Proc. 2021 Nov; 96 (11):2746-2747
    View PubMed
  30. Gupta S, Erickson LA, Lohse CM, Shen W, Pitel BA, Knight SM, Halling KC, Herrera-Hernandez L, Boorjian SA, Thompson RH, Leibovich BC, Jimenez RE, Cheville JC. Assessment of Risk of Hereditary Predisposition in Patients With Melanoma and/or Mesothelioma and Renal Neoplasia. JAMA Netw Open. 2021 Nov 1; 4 (11):e2132615 Epub 2021 Nov 01
    View PubMed
  31. Rizzo NM, Sholl LM, Idrees MT, Cheville JC, Gupta S, Cornejo KM, Miyamoto H, Hirsch MS, Collins K, Acosta AM. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features. Mod Pathol. 2021 Oct; 34 (10):1935-1946 Epub 2021 June 08
    View PubMed
  32. Gupta S, Erickson LA. Renal Neoplasia in Hyperparathyroidism-Jaw Tumor Syndrome. Mayo Clin Proc. 2021 Oct; 96 (10):2730-2731
    View PubMed
  33. Wang XM, Zhang Y, Mannan R, Skala SL, Rangaswamy R, Chinnaiyan A, Su F, Cao X, Zelenka-Wang S, McMurry L, Xiao H, Spratt DE, Sangoi AR, Shao L, Betz BL, Brown N, Tickoo SK, McKenney JK, Argani P, Gupta S, Reuter VE, Chinnaiyan AM, Dhanasekaran SM, Mehra R. TRIM63 is a sensitive and specific biomarker for MiT family aberration-associated renal cell carcinoma. Mod Pathol. 2021 Aug; 34 (8):1596-1607 Epub 2021 Apr 14
    View PubMed
  34. Kravtsov O, Gupta S, Cheville JC, Sukov WR, Rowsey R, Herrera-Hernandez LP, Lohse CM, Knudson R, Leibovich BC, Jimenez RE. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics. Hum Pathol. 2021 Aug; 114:9-18 Epub 2021 May 04
    View PubMed
  35. Amin MB, Comperat E, Epstein JI, True LD, Hansel D, Paner GP, Al-Ahmadie H, Baydar D, Bivalacqua T, Brimo F, Cheng L, Cheville J, Dalbagni G, Falzarano S, Gordetsky J, Guo CC, Gupta S, Hes O, Iyer G, Kaushal S, Kunju L, Magi-Galluzzi C, Matoso A, Netto G, Osunkoya AO, Pan CC, Pivovarcikova K, Raspollini MR, Reis H, Rosenberg J, Roupret M, Shah RB, Shariat S, Trpkov K, Weyerer V, Zhou M, McKenney J, Reuter VE. The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Adv Anat Pathol. 2021 Jul 1; 28 (4):179-195
    View PubMed
  36. Comperat E, Amin MB, Epstein JI, Hansel DE, Paner G, Al-Ahmadie H, True L, Baydar D, Bivalacqua T, Brimo F, Cheng L, Cheville J, Dalbagni G, Falzarano S, Gordetsky J, Guo C, Gupta S, Hes O, Iyer G, Kaushal S, Kunju L, Magi-Galluzzi C, Matoso A, McKenney J, Netto GJ, Osunkoya AO, Pan CC, Pivovarcikova K, Raspollini MR, Reis H, Rosenberg J, Roupret M, Shah RB, Shariat SF, Trpkov K, Weyerer V, Zhou M, Reuter V. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol. 2021 Jul 1; 28 (4):196-208
    View PubMed
  37. Trpkov K, Hes O, Williamson SR, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Gill AJ. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021 Jul; 34 (7):1392-1424 Epub 2021 Mar 04
    View PubMed
  38. Gupta S, Erickson LA. Primary Renal Well-Differentiated Neuroendocrine Tumor (Carcinoid) in a Horseshoe Kidney. Mayo Clin Proc. 2021 Jun; 96 (6):1687-1688
    View PubMed
  39. Freitag CE, Sukov WR, Bryce AH, Berg JV, Vanderbilt CM, Shen W, Smadbeck JB, Greipp PT, Ketterling RP, Jenkins RB, Herrera-Hernandez L, Costello BA, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE, Murphy SJ, Vasmatzis G, Cheville JC, Gupta S. Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing. Hum Pathol. 2021 Jun; 112:20-34 Epub 2021 Mar 31
    View PubMed
  40. Gupta S, Jimenez RE, Herrera-Hernandez L, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Cheville JC. Renal Neoplasia in Tuberous Sclerosis: A Study of 41 Patients. Mayo Clin Proc. 2021 Jun; 96 (6):1470-1489 Epub 2021 Jan 29
    View PubMed
  41. Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021 Jun; 34 (6):1167-1184 Epub 2021 Feb 01
    View PubMed
  42. Krishna C, DiNatale RG, Kuo F, Srivastava RM, Vuong L, Chowell D, Gupta S, Vanderbilt C, Purohit TA, Liu M, Kansler E, Nixon BG, Chen YB, Makarov V, Blum KA, Attalla K, Weng S, Salmans ML, Golkaram M, Liu L, Zhang S, Vijayaraghavan R, Pawlowski T, Reuter V, Carlo MI, Voss MH, Coleman J, Russo P, Motzer RJ, Li MO, Leslie CS, Chan TA, Hakimi AA. Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. Cancer Cell. 2021 May 10; 39 (5):662-677.e6 Epub 2021 Apr 15
    View PubMed
  43. Akgul M, Williamson SR, Ertoy D, Argani P, Gupta S, Calio A, Reuter V, Tickoo S, Al-Ahmadie HA, Netto GJ, Hes O, Hirsch MS, Delahunt B, Mehra R, Skala S, Osunkoya AO, Harik L, Rao P, Sangoi AR, Nourieh M, Zynger DL, Smith SC, Nazeer T, Gumuskaya B, Kulac I, Khani F, Tretiakova MS, Vakar-Lopez F, Barkan G, Molinie V, Verkarre V, Rao Q, Kis L, Panizo A, Farzaneh T, Magers MJ, Sanfrancesco J, Perrino C, Gondim D, Araneta R, So JS, Ro JY, Wasco M, Hameed O, Lopez-Beltran A, Samaratunga H, Wobker SE, Melamed J, Cheng L, Idrees MT. Diagnostic approach in TFE3-rearranged renal cell carcinoma: a multi-institutional international survey. J Clin Pathol. 2021 May; 74 (5):291-299 Epub 2021 Jan 29
    View PubMed
  44. Trpkov K, Williamson SR, Gill AJ, Adeniran AJ, Agaimy A, Alaghehbandan R, Amin MB, Argani P, Chen YB, Cheng L, Epstein JI, Cheville JC, Comperat E, da Cunha IW, Gordetsky JB, Gupta S, He H, Hirsch MS, Humphrey PA, Kapur P, Kojima F, Lopez JI, Maclean F, Magi-Galluzzi C, McKenney JK, Mehra R, Menon S, Netto GJ, Przybycin CG, Rao P, Rao Q, Reuter VE, Saleeb RM, Shah RB, Smith SC, Tickoo S, Tretiakova MS, True L, Verkarre V, Wobker SE, Zhou M, Hes O. Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia. Mod Pathol. 2021 May; 34 (5):1037
    View PubMed
  45. Gupta S, Erickson LA. Paratesticular Papillary Cystadenoma of the Epididymis in the Setting of von Hippel-Lindau. Mayo Clin Proc. 2021 Mar; 96 (3):828-829
    View PubMed
  46. Avulova S, Cheville JC, Lohse CM, Gupta S, Potretzke TA, Tsivian M, Thompson RH, Boorjian SA, Leibovich BC, Potretzke AM. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol. 2021 Feb; 79 (2):225-231 Epub 2020 Nov 07
    View PubMed
  47. Zhao Y, Yu H, Ida CM, Halling KC, Kipp BR, Geiersbach K, Rumilla KM, Gupta S, Lin MT, Zheng G. Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases. JAMA Netw Open. 2021 Jan 4; 4 (1):e2035479 Epub 2021 Jan 04
    View PubMed
  48. Gupta S, Vanderbilt CM, Zhang Y, Tickoo SK, Fine SW, Gopalan A, Chen YB, Sirintrapun SJ, Teo MY, Funt SA, Iyer G, Rosenberg JE, Bajorin DF, Bochner BH, Pietzak EJ, Ross DS, Ladanyi M, Cheville JC, Solit DB, Reuter VE, Al-Ahmadie HA. CD274 (PD-L1) Copy Number Changes (Gain) & Response to Immune Checkpoint Blockade Therapy in Carcinomas of the Urinary Tract. Bladder Cancer. 2021; 7 (4):395-400 Epub 2021 Dec 13
    View PubMed
  49. Gupta S, Cheville JC, Galeano BK, Sukov WR, Herrera-Hernandez L, Reed KA, Lohse CM, Thompson RH, Boorjian SA, Leibovich BC, Jimenez RE. Renal neoplasia with papillary architecture involving the pelvicalyceal system. Hum Pathol. 2021 Jan; 107:46-57 Epub 2020 Nov 06
    View PubMed
  50. Gupta S, Vanderbilt CM, Lin YT, Benhamida JK, Jungbluth AA, Rana S, Momeni-Boroujeni A, Chang JC, Mcfarlane T, Salazar P, Mullaney K, Middha S, Zehir A, Gopalan A, Bale TA, Ganly I, Arcila ME, Benayed R, Berger MF, Ladanyi M, Dogan S. A Pan-Cancer Study of Somatic TERT Promoter Mutations and Amplification in 30,773 Tumors Profiled by Clinical Genomic Sequencing. J Mol Diagn. 2020 Dec 5 Epub 2020 Dec 05
    View PubMed
  51. Aron M, Park S, Lowenthal BM, Gupta S, Sahoo D, Cheville JC, Hansel DE. Primary Female Urethral Carcinoma: Proposed Staging Modifications Based on Assessment of Female Urethral Histology and Analysis of a Large Series of Female Urethral Carcinomas. Am J Surg Pathol. 2020 Dec; 44 (12):1591-1601
    View PubMed
  52. Gupta S, Erickson LA. Renal Neoplasia in Cowden Syndrome. Mayo Clin Proc. 2020 Dec; 95 (12):2808-2809
    View PubMed
  53. Blum KA, Gupta S, Tickoo SK, Chan TA, Russo P, Motzer RJ, Karam JA, Hakimi AA. Sarcomatoid renal cell carcinoma: biology, natural history and management. Nat Rev Urol. 2020 Oct 13 [Epub ahead of print]
    View PubMed
  54. Mata DA, Yang SR, Ferguson DC, Liu Y, Sharma R, Benhamida JK, Al-Ahmadie HA, Chakravarty D, Solit DB, Tickoo SK, Gupta S, Arcila ME, Ladanyi M, Feldman DR, Reuter VE, Vanderbilt CM. RAS/MAPK Pathway Driver Alterations Are Significantly Associated With Oncogenic KIT Mutations in Germ-cell Tumors. Urology. 2020 Oct; 144:111-116 Epub 2020 July 25
    View PubMed
  55. Gupta S, Vanderbilt CM, Leibovich BC, Herrera-Hernandez L, Raghunathan A, Sukov WR, Voss JS, Barr Fritcher EG, Reed KA, Lohse CM, Reuter VE, Jimenez RE, Thompson RH, Cheville JC. Secondary renal neoplasia following chemotherapy or radiation in pediatric patients. Hum Pathol. 2020 Sep; 103:1-13 Epub 2020 July 15
    View PubMed
  56. Gupta S, Inwards CY, Van Dyke DL, Jimenez RE, Cheville JC. Defining clear cell papillary renal cell carcinoma in routine clinical practice. Histopathology 2020 Jun; 76 (7):1093-1095 Epub 2020 May 07
    View PubMed
  57. Gupta S, Erickson LA. Tuberous Sclerosis-Associated Renal Neoplasm. Mayo Clin Proc. 2020 May; 95 (5):1089-1090
    View PubMed
  58. Marcon J, DiNatale RG, Sanchez A, Kotecha RR, Gupta S, Kuo F, Makarov V, Sandhu A, Mano R, Silagy AW, Blum KA, Nassau DE, Benfante NE, Ortiz MV, Carlo MI, Chan TA, Motzer RJ, Voss MH, Coleman J, Russo P, Reuter V, Hakimi AA, Reznik E. Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy number variations as drivers of disease progression. Clin Cancer Res. 2020 Mar 27 [Epub ahead of print]
    View PubMed
  59. Gupta S, Erickson LA. Fumarate Hydratase-Deficient Renal Cell Carcinoma. Mayo Clin Proc. 2020 Mar; 95 (3):619-621
    View PubMed
  60. Gupta S, Vanderbilt C, Abida W, Fine SW, Tickoo SK, Al-Ahmadie HA, Chen YB, Sirintrapun SJ, Chadalavada K, Nanjangud GJ, Bialik A, Morris MJ, Scher HI, Ladanyi M, Reuter VE, Gopalan A. Immunohistochemistry-based assessment of androgen receptor status and the AR-null phenotype in metastatic castrate resistant prostate cancer. Prostate Cancer Prostatic Dis. 2020 Feb 24 [Epub ahead of print]
    View PubMed
  61. Gupta S, Fine SW, Chang J, Tickoo SK, Chen YB, Al-Ahmadie HA, Sirintrapun SJ, Abida W, Ladanyi M, Reuter VE, Gopalan A. Morphologic and Immunohistochemical Assessment of CDH1 Loss of Function Alterations in Prostatic Adenocarcinoma. Am J Surg Pathol. 2019 Dec 24 [Epub ahead of print]
    View PubMed
  62. Chang JC, Alex D, Bott M, Tan KS, Seshan V, Golden A, Sauter JL, Buonocore DJ, Vanderbilt CM, Gupta S, Desmeules P, Bodd FM, Riely GJ, Rusch VW, Jones DR, Arcila ME, Travis WD, Ladanyi M, Rekhtman N. Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach. Clin Cancer Res. 2019 Dec 1; 25 (23):7113-7125 Epub 2019 Aug 30
    View PubMed
  63. Gupta S, Ito T, Alex D, Vanderbilt CM, Chang JC, Islamdoust N, Zhang Y, Nafa K, Healey J, Ladanyi M, Hameed MR. RUNX2 (6p21.1) amplification in osteosarcoma. Hum Pathol. 2019 Dec; 94:23-28 Epub 2019 Oct 25
    View PubMed
  64. Gupta S, Argani P, Jungbluth AA, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Sanchez A, Hakimi AA, Mcfarlane T, Salazar PA, Williamson SR, Skala SL, Mehra R, Hes O, Antonescu CR, Ladanyi M, Arcila ME, Reuter VE. TFEB Expression Profiling in Renal Cell Carcinomas: Clinicopathologic Correlations. Am J Surg Pathol. 2019 Nov; 43 (11):1445-1461
    View PubMed
  65. Gupta S, Cheville JC, Jungbluth AA, Zhang Y, Zhang L, Chen YB, Tickoo SK, Fine SW, Gopalan A, Al-Ahmadie HA, Sirintrapun SJ, Blum KA, Lohse CM, Hakimi AA, Thompson RH, Leibovich BC, Berger MF, Arcila ME, Ross DS, Ladanyi M, Antonescu CR, Reuter VE. JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management. Mod Pathol. 2019 Sep; 32 (9):1344-1358 Epub 2019 Apr 17
    View PubMed
  66. Gupta S, Swanson AA, Chen YB, Lopez T, Milosevic D, Kipp BR, Leibovich BC, Thompson RH, Herrera-Hernandez L, Cheville JC, Jimenez RE. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC. Hum Pathol. 2019 Sep; 91:114-122 Epub 2019 July 09
    View PubMed
  67. Walasek A, Gupta S, Fine S, Russo P. Juxtaglomerular Cell Tumor: A Rare, Curable Cause of Hypertension in a Young Patient. Urology. 2019 Jun 21 Epub 2019 June 21
    View PubMed
  68. Hau AM, Gupta S, Leivo MZ, Nakashima K, Macias J, Zhou W, Hodge A, Wulfkuhle J, Conkright B, Bhuvaneshwar K, Rao S, Madhavan S, Petricoin EF 3rd, Hansel DE. Dynamic Regulation of Caveolin-1 Phosphorylation and Caveolae Formation by Mammalian Target of Rapamycin Complex 2 in Bladder Cancer Cells. Am J Pathol. 2019 Jun 11 Epub 2019 June 11
    View PubMed
  69. Gupta S, Sosa CP, Kosari F, Folpe A, Bhinge KN, Yang L, Agahi A, Johnson SH, Frank I, Boorjian SA, Hansel DE, Al-Ahmadie HA, Reuter VE, Vasmatzis G, Jimenez RE, Herrera-Hernandez L, Cheville JC. A comparison of adult rhabdomyosarcoma and high-grade neuroendocrine carcinoma of the urinary bladder reveals novel PPP1R12A fusions in rhabdomyosarcoma. Hum Pathol. 2019 Jun; 88:48-59 Epub 2019 Apr 01
    View PubMed
  70. Gupta S, Vanderbilt CM, Cotzia P, Arias Stella JA 3rd, Chang JC, Chen Y, Tang LH, DeLair DF, Yao J, Ladanyi M, Ross DS. JAK2, PD-L1, and PD-L2 (9p24.1) amplification in metastatic mucosal and cutaneous melanomas with durable response to immunotherapy. Hum Pathol. 2019 Jun; 88:87-91 Epub 2018 Sept 18
    View PubMed
  71. Gupta S, Vanderbilt CM, Cotzia P, Arias-Stella JA 3rd, Chang JC, Zehir A, Benayed R, Nafa K, Razavi P, Hyman DM, Baselga J, Berger MF, Ladanyi M, Arcila ME, Ross DS. Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management. J Mol Diagn. 2019 Mar; 21 (2):307-317 Epub 2018 Dec 18
    View PubMed
  72. Gupta S, Sahu D, Bomalaski JS, Frank I, Boorjian SA, Thapa P, Cheville JC, Hansel DE. Argininosuccinate Synthetase-1 (ASS1) Loss in High-Grade Neuroendocrine Carcinomas of the Urinary Bladder: Implications for Targeted Therapy with ADI-PEG 20. Endocr Pathol. 2018 Sep; 29 (3):236-241
    View PubMed
  73. Gupta S, Zhang J, Erickson LA. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase. Endocr Pathol. 2017 Sep; 28 (3):269-275
    View PubMed
  74. Gupta S, Zhang J, Milosevic D, Mills JR, Grebe SK, Smith SC, Erickson LA. Primary Renal Paragangliomas and Renal Neoplasia Associated with Pheochromocytoma/Paraganglioma: Analysis of von Hippel-Lindau (VHL), Succinate Dehydrogenase (SDHX) and Transmembrane Protein 127 (TMEM127). Endocr Pathol. 2017 Sep; 28 (3):253-268
    View PubMed
  75. Gupta S, Johnson SH, Vasmatzis G, Porath B, Rustin JG, Rao P, Costello BA, Leibovich BC, Thompson RH, Cheville JC, Sukov WR. TFEB-VEGFA (6p21.1) co-amplified renal cell carcinoma: a distinct entity with potential implications for clinical management. Mod Pathol. 2017 Jul; 30 (7):998-1012 Epub 2017 Mar 24
    View PubMed
  76. Muppa P, Gupta S, Frank I, Boorjian SA, Karnes RJ, Thompson RH, Thapa P, Tarrell RF, Herrera Hernandez LP, Jimenez RE, Cheville JC. Prognostic significance of lymphatic, vascular and perineural invasion for bladder cancer patients treated by radical cystectomy. Pathology. 2017 Apr; 49: (3)259-266.
    View PubMed
  77. Gupta S, Erickson LA. Testicular Seminoma. Mayo Clin Proc. 2017 Feb; 92 (2):e21-e22
    View PubMed
  78. Sahu D, Gupta S, Hau AM, Nakashima K, Leivo MZ, Searles SC, Elson P, Bomalaski JS, Casteel DE, Boss GR, Hansel DE. Argininosuccinate Synthetase 1 Loss in Invasive Bladder Cancer Regulates Survival through General Control Nonderepressible 2 Kinase-Mediated Eukaryotic Initiation Factor 2alpha Activity and Is Targetable by Pegylated Arginine Deiminase. Am J Pathol. 2017 Jan; 187 (1):200-213 Epub 2016 Dec 09
    View PubMed
  79. Gupta S, Erickson LA. Paratesticular Adenomatoid Tumor. Mayo Clin Proc. 2016 Dec; 91 (12):e167-e168
    View PubMed
  80. Gupta S, Jimenez RE, Folpe AL, Cheville JC. Renal Leiomyoma and Leiomyosarcoma: A Study of 57 Cases. Am J Surg Pathol. 2016 Nov; 40 (11):1557-1563
    View PubMed
  81. Gupta S, Zhang J, Rivera M, Erickson LA. Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome. Endocr Pathol. 2016 Sep; 27 (3):243-52
    View PubMed
  82. Sanfrancesco J, McKenney JK, Leivo MZ, Gupta S, Elson P, Hansel DE. Sarcomatoid Urothelial Carcinoma of the Bladder: Analysis of 28 Cases With Emphasis on Clinicopathologic Features and Markers of Epithelial-to-Mesenchymal Transition. Arch Pathol Lab Med. 2016 Jun; 140 (6):543-51 Epub 2016 Mar 31
    View PubMed
  83. Gupta S, Hau AM, Al-Ahmadie HA, Harwalkar J, Shoskes AC, Elson P, Beach JR, Hussey GS, Schiemann WP, Egelhoff TT, Howe PH, Hansel DE. Transforming Growth Factor-beta Is an Upstream Regulator of Mammalian Target of Rapamycin Complex 2-Dependent Bladder Cancer Cell Migration and Invasion. Am J Pathol. 2016 May; 186 (5):1351-60 Epub 2016 Mar 14
    View PubMed
  84. Gupta S, Naini BV, Munoz R, Graham RP, Kipp BR, Torbenson MS, Mounajjed T. Hepatocellular Neoplasms Arising in Association With Androgen Use. Am J Surg Pathol. 2016 Apr; 40: (4)454-61.
    View PubMed
  85. Gupta S, Herrera Hernandez LP, Erickson LA. Diagnosing a Kidney Tumor. Mayo Clin Proc. 2016 Mar; 91: (3)e41-2.
    View PubMed
  86. Gupta S, Erickson LA. Young Female Patient With a Hepatic Adenoma: Determining Risk for Malignant Transformation. Mayo Clin Proc. 2016 Feb; 91: (2)e29-30.
    View PubMed
  87. Gupta S, Erickson LA. Pancreatic Tumor in a Patient With Parathyroid and Pituitary Disease. Mayo Clin Proc. 2016 Jan; 91 (1):e17-8
    View PubMed
  88. Gupta S, Thompson RH, Boorjian SA, Thapa P, Hernandez LP, Jimenez RE, Costello BA, Frank I, Cheville JC. High grade neuroendocrine carcinoma of the urinary bladder treated by radical cystectomy: a series of small cell, mixed neuroendocrine and large cell neuroendocrine carcinoma. Pathology. 2015 Oct; 47 (6):533-42
    View PubMed
  89. Poterucha JT, Johnson JN, Qureshi MY, O'Leary PW, Kamath PS, Lennon RJ, Bonnichsen CR, Young PM, Venkatesh SK, Ehman RL, Gupta S, Smyrk TC, Dearani JA, Warnes CA, Cetta F. Magnetic Resonance Elastography: A Novel Technique for the Detection of Hepatic Fibrosis and Hepatocellular Carcinoma After the Fontan Operation. Mayo Clin Proc. 2015 Jul; 90 (7):882-94 Epub 2015 June 06
    View PubMed
  90. Lohse CM, Gupta S, Cheville JC. Outcome prediction for patients with renal cell carcinoma. Semin Diagn Pathol. 2015 Mar; 32 (2):172-83 Epub 2015 Feb 07
    View PubMed
  91. Khare R, Gupta S, Arif S, Jentoft ME, Deziel PJ, Roden AC, Wilhelm MP, Razonable RR, Wengenack NL. Misidentification of Neosartorya pseudofischeri as Aspergillus fumigatus in a lung transplant patient. J Clin Microbiol. 2014 Jul; 52 (7):2722-5 Epub 2014 May 14
    View PubMed
  92. Guin S, Pollard C, Ru Y, Ritterson Lew C, Duex JE, Dancik G, Owens C, Spencer A, Knight S, Holemon H, Gupta S, Hansel D, Hellerstein M, Lorkiewicz P, Lane AN, Fan TW, Theodorescu D. Role in tumor growth of a glycogen debranching enzyme lost in glycogen storage disease. J Natl Cancer Inst. 2014 Apr 3; 106 (5) Epub 2014 Apr 03
    View PubMed
  93. Gupta S, Hau AM, Beach JR, Harwalker J, Mantuano E, Gonias SL, Egelhoff TT, Hansel DE. Mammalian target of rapamycin complex 2 (mTORC2) is a critical determinant of bladder cancer invasion. PLoS One. 2013; 8 (11):e81081 Epub 2013 Nov 27
    View PubMed
  94. Xu X, Gupta S, Hu W, McGrath BC, Cavener DR. Hyperthermia induces the ER stress pathway. PLoS One. 2011; 6 (8):e23740 Epub 2011 Aug 18
    View PubMed
  95. Cavener DR, Gupta S, McGrath BC. PERK in beta cell biology and insulin biogenesis. Trends Endocrinol Metab. 2010 Dec; 21 (12):714-21 Epub 2010 Sept 17
    View PubMed
  96. Gupta S, McGrath B, Cavener DR. PERK (EIF2AK3) regulates proinsulin trafficking and quality control in the secretory pathway. Diabetes. 2010 Aug; 59 (8):1937-47 Epub 2010 June 08
    View PubMed
  97. Gupta S, McGrath B, Cavener DR. PERK regulates the proliferation and development of insulin-secreting beta-cell tumors in the endocrine pancreas of mice. PLoS One. 2009 Nov 24; 4 (11):e8008
    View PubMed
  98. Feng D, Wei J, Gupta S, McGrath BC, Cavener DR. Acute ablation of PERK results in ER dysfunctions followed by reduced insulin secretion and cell proliferation. BMC Cell Biol. 2009 Sep 4; 10:61 Epub 2009 Sept 04
    View PubMed